| REVVITY INC. DL 1 |
| USA |
| Gesundheit |
| US7140461093 / 850943 |
| PKN (Frankfurt) / RVTY (NYSE) |
| FRA:PKN, ETR:PKN, PKN:GR, NYSE:RVTY |
| S&P500 |
| https://www.revvity.com/ |
|
Revvity Inc. is a prominent company in the healthcare and biological sciences field, offering a comprehensive suite of solutions aimed at improving global health outcomes. The company's core focus lies in delivering innovative products and services t..
>Volltext.. |
| 8515.66 Mio. EUR |
| 10624.8 Mio. EUR |
| 2474.24 Mio. EUR |
| 722.99 Mio. EUR |
| 209.66 Mio. EUR |
| 1.82 EUR |
| 2943.92 Mio. EUR |
| 796.89 Mio. EUR |
| 502.86 Mio. EUR |
| 0.69 |
| -8.63% |
| -27.89% |
| 0.24 EUR |
| 0.33% |
| 0.32% |
| 16.01.26 - 0.060234997€ 17.10.25 - 0.06006€ >weitere anzeigen... |
| - |
| REVVITY, PERKINELMER, PERKIN ELMER |
| 03.04.26 |
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|